Tuesday, October 29, 2024, 6.00pm to 8.00pm EDT
Cambridge in America welcomes you to a special event with Professor Alasdair Coles.
You're invited to join the leading authority in neuroimmunology, Head of the Department of Clinical Neurosciences at Cambridge, Professor Alasdair Coles, for an insightful talk and drinks reception in New York on Tuesday, October 29 at 6.00pm.
Professor Alasdair Coles will present a thought-provoking talk on the future of neuroimmunology research and its profound implications for neurological conditions. He will explore cutting-edge research that links immune dysregulation to diseases such as multiple sclerosis, Parkinson’s disease, and depression.
Please join us to learn more about emerging therapies and the potential for personalized medicine and the critical importance of interdisciplinary collaboration.
We look forward to seeing you there!
Date: Tuesday, October 29
Time: 6:00pm - 8:00pm ET
Location: Elevated NY, 4th Floor, 1120 Avenue of the Americas, New York, NY 10036
Professor Alasdair Coles is Professor of Neuroimmunology, Head of the Department of Clinical Neurosciences, University of Cambridge and Co-Director of Cambridge Neuroscience.
He led the development of alemtuzumab as a treatment for multiple sclerosis (MS), from 1994 to its licensing in 2014, being first author on open-label studies and subsequent trial phases. Alasdair has led the Cambridge MS research teams to change focus to strategies to promote remyelination. This coincided with his co-director of the MS Society’s Centre of Excellence, the Cambridge Centre for Myelin Repair (CCMR).
You can read more about Professor Alasdair Coles here.
Booking information
Booking for this event is now closed.
